ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
3075Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 5,054 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 6.32% of the total position.
ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 11,822 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.27% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 4,168 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.37% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 4,398 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.34% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 1,128 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 4.48% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 4,150 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.98% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 7,670 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 8.7% of the total position.
ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 8,800 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.92% of the total position.
ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 47,809 shares, the number of shares held increased 9.99% compared to the previous period and now represents 1.79% of the total position.
ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 8,244 shares, the number of shares held increased 0.94% compared to the previous period and now represents 1.48% of the total position.
ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 9,300 shares, the number of shares held increased 0.42% compared to the previous period and now represents 4.25% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,106 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.71% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 5,610 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 8.16% of the total position.
ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 3,066 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 18,867 shares, the number of shares held decreased 0.14% compared to the previous period and now represents 2.8% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 5,062 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.02% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 15,740 shares, the number of shares held decreased 1.18% compared to the previous period and now represents 7.56% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 2,120 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.98% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 7,240 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.39% of the total position.
ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 28,018 shares, the number of shares held decreased 0.28% compared to the previous period and now represents 6.23% of the total position.
Go to Tiger App to see more news